What is the updated interpretation of the tuberculin skin test (TST) based on induration size and BCG vaccination history?

Updated Interpretation of the Tuberculin Skin Test

The tuberculin skin test (TST) should be interpreted using risk-stratified cutoff values: ≥5 mm for high-risk individuals (HIV-positive, close TB contacts, immunosuppressed, TNF blocker recipients), ≥10 mm for moderate-risk groups (foreign-born from high-burden countries, healthcare workers, those with medical risk factors), and ≥15 mm for low-risk persons, with BCG vaccination history no longer considered a reason to disregard positive results. 1

Administration and Reading

• The TST is administered via intradermal injection of 0.1 mL of purified protein derivative (PPD, 5 TU) into the volar forearm surface using the Mantoux method to produce a transient wheal 1
• The test must be read at 48-72 hours by measuring the transverse diameter of palpable induration (not erythema) 1

Risk-Stratified Interpretation Thresholds

≥5 mm Positive Cutoff 1

• Close contacts of active tuberculosis cases
• HIV-infected persons and other immunosuppressed individuals
• Patients with clinical or radiographic evidence of current or prior TB
• Persons receiving TNF-blocking agents (biologics)

≥10 mm Positive Cutoff 1

• Foreign-born persons from high TB-incidence countries
• Healthcare workers and others with occupational TB exposure risk
• Residents and employees of high-risk congregate settings
• Persons with medical conditions increasing progression risk (diabetes, chronic renal failure, malignancies, silicosis)

≥15 mm Positive Cutoff 1

• All other persons with no known risk factors

Critical Update: BCG Vaccination Interpretation

BCG vaccination history should NOT be used to dismiss positive TST results, particularly when induration exceeds 10 mm. This represents a significant shift from older practices:

• BCG vaccination decreases TST specificity, especially with post-infancy vaccination or repeat vaccination 1
• However, BCG's effect on TST can persist up to 55 years after vaccination, far longer than the 10-year period conventionally accepted 2
• When TST induration is >10 mm in BCG-vaccinated individuals, the reaction is statistically more likely due to latent TB infection than BCG cross-reactivity 3
• TST reactions ≤18 mm in BCG-vaccinated persons under 40 years old require cautious interpretation in low-incidence areas, as these may reflect vaccination rather than infection 4
• In high-risk populations (TB contacts, endemic country exposure), even moderate TST reactions in BCG-vaccinated individuals should be considered true positives 5

Test Performance Characteristics

Sensitivity 1

• High sensitivity (95-98%) in clinically well persons with previously treated tuberculosis
• False-negative reactions occur in:
  • Infants and young children
  • Early infection (<6-8 weeks post-exposure)
  • Recent viral vaccination recipients
  • Immunosuppressed patients (HIV, high-dose corticosteroids, TNF inhibitors)
  • Overwhelming or disseminated tuberculosis
  • Recent viral or bacterial infections

Specificity 1

• Reduced specificity in BCG-vaccinated persons, particularly with post-infancy or repeat vaccination
• False-positive reactions in areas with common nontuberculous mycobacteria exposure

Boosting Phenomenon 1

• Repeated TST administration cannot induce new reactivity
• However, repeat testing can restore waned reactivity in previously infected persons
• For persons undergoing periodic TST screening who have not been tested recently (e.g., within 1 year), initial two-step testing is recommended to establish a true baseline and avoid misinterpreting boosted reactions as new conversions

Clinical Pitfalls to Avoid

• Do not automatically attribute positive TST results to BCG vaccination, especially when induration is ≥10 mm or the patient has TB risk factors 3, 5
• Do not rely solely on TST in immunocompromised patients where false-negatives are common; consider interferon-gamma release assays (IGRAs) as complementary tests 1
• Do not interpret erythema alone—only measure induration 1
• Do not dismiss the possibility of TB in BCG-vaccinated healthcare workers or immigrants from high-burden countries with positive TST results 4, 5